p53 Mutation Lung Cancer: VCU Achilles' Heel | AcademicJobs
VCU Massey researchers uncover a key weakness in p53 mutations driving lung cancer, paving the way for targeted therapies via checkpoint inhibitors.
No reviews yet. Be the first to rate Sumitra!
Sumitra Deb, Ph.D., serves as a professor in the Department of Biochemistry and Molecular Biology at the Virginia Commonwealth University School of Medicine. Her work is affiliated with the VCU Massey Cancer Center, where she conducts research in cancer biology with a focus on molecular mechanisms involving the p53 tumor suppressor and related therapeutic approaches. She has contributed to studies on viral-based gene therapies for lung cancer, including projects supported by grants from the National Cancer Institute. Dr. Deb collaborates with other researchers at VCU, including Swati Palit Deb, Ph.D., on investigations into cancer cell pathways and potential treatment targets.
VCU Massey researchers uncover a key weakness in p53 mutations driving lung cancer, paving the way for targeted therapies via checkpoint inhibitors.